Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonary aspergillosis

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 2, 1996, Pages 215-225

  Leenders, A C A P ^a   De Marie, S ^a   Ten Kate, M T ^b   Bakker Woudenberg, I A J M ^b   Verbrugh, H A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRANULOCYTOPENIA; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER DISEASE; LUNG ASPERGILLOSIS; NONHUMAN; PROPHYLAXIS; RAT; SPLEEN DISEASE; SURVIVAL; TISSUE CULTURE;

EID: 0029744880     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.2.215     Document Type: Article

References (24)

1. Adler-Moore, J. P. & Proffitt, R. T. (1993). Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. Journal of Liposome Research 3, 429-50.
2. Bakker-Woudenberg, I. A. J. M., Van den Berg, J. C. & Michel, M. F. (1982). Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats. Antimicrobial Agents and Chemotherapy 22, 1042-50.
3. de Marie, S., Janknegt, R. & Bakker-Woudenberg, I. A. J. M. (1994). Clinical use of liposomal and lipid-complexed amphotericin B. Journal of Antimicrobial Chemotherapy 33, 907-16.
4. Denning, D. W., Follansbee, S. E., Scolaro, M., Norris, S., Edelstein, H. & Stevens, D. A. (1991). Pulmonary aspergillosis in the acquired immunodeficiency syndrome. New England Journal of Medicine 324, 654-62.
5. Denning, D. W. & Stevens, D. A. (1990). Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Reviews of Infectious Diseases 12, 1147-201.
6. Dixon, D. M., Polak, A. & Walsh, T. J. (1989). Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infection and Immunity 57, 1452-6.
7. Francis, P., Lee, J. W., Hoffman, A., Peter, J., Francesconi, A., Bacher, J. et al. (1994). Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannam as markers of infection. Journal of Infectious Diseases 169, 356-68.
8. Gerson, S. L., Talbot, G. H., Lusk, E., Hurwitz, S., Strom, B. L. & Cassileth, P. A. (1985). Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. Journal of Clinical Oncology 3, 1109-16.
9. Graybill, J. R. & Kaster, S. R. (1984). Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. American Reviews of Respiratory Diseases 129, 292-5.
10. Graybill, J. R., Kaster, S. R. & Drutz, D. J. (1983). Treatment of experimental murine aspergillosis with BAY n7133. Journal of Infectious Diseases 148, 898-906.
11. Khoo, S. H. & Denning, D. W. (1994). Invasive aspergillosis in patients with AIDS. Clinical Infectious Diseases 19, Suppl. 1, 41-8.
12. Lopez-Berestein, G., Fainstein, V., Hopfer, R., Mehta, K., Sullivan, M. P., Keating, M. et al. (1985). Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. Journal of Infectious Diseases 151, 704-10.
13. McWhinney, P. H. M., Kibbler, C. C., Hamon, M. D., Smith, O. P., Gandhi, L., Berger, L. A. et al. (1993). Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clinical Infectious Diseases 17, 397-404.
14. Meunier, F., Prentice, H. G. & Ringden, O. (1991). Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. Journal of Antimicrobial Chemotherapy 28, Suppl. B, 83-91.
15. Mills, W., Chopra, R., Linch, D. C. & Goldstone, A. H. (1994). Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. British Journal of Haematology 86, 754-60.
16. Niki, Y., Bernard, E. M., Edwards, F. F., Schmitt, H. J., Yu, B. & Armstrong, D. (1991). Model of recurrent pulmonary aspergillosis in rats. Journal of Clinical Microbiology 29, 1317-22.
17. Patterson, T. F., Miniter, P., Dijkstra, J., Szoka, F. C., Ryan, J. L. & Andriole, V. T. (1989). Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. Journal of Infectious Diseases 159, 717-24.
18. Proffitt, R. T., Satorius, A., Chiang, S.-M., Sullivan, L. & Adler-Moore, J. P. (1991). Pharmacology and toxicity of a liposomal formulation of amphotericin B (AmBisome) in rodents. Journal of Antimicrobial Chemotherapy 28, Suppl. B, 49-61.
19. Rinaldi, M. G. (1983). Invasive aspergillosis. Reviews of Infectious Diseases 5, 1061-77.
20. Roosendaal, R., Bakker-Woudenberg, I. A. J. M., van-den-Berghe-van-Rafle, M., Vink-van-den-Berg, J. C. & Michel, M. F. (1991). Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. European Journal of Clinical Microbiology and Infectious Diseases 10, 1019-25.
21. Ruutu, P., Valtonen, V., Elonen, E., Volin, L., Tukiainen, P. & Ruutu, T. (1987). Invasive pulmonary aspergillosis: a diagnostic and therapeutic problem. Scandinavian Journal of Infectious Diseases 19, 569-75.
22. Schmitt, H. J., Bernard, E. M., Hauser, M. & Armstrong, D. (1988). Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy 32, 1676-9.
23. Van Cutsem, J., Van Gerven, F. & Janssen, P. A. J. (1987). Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models, reviews of Infectious Diseases 9, Suppl. 1, 15-32.
24. van Etten, E. W. M., Otte-Lambillion, M., van Vianen, W., ten Kate, M. T. & Bakker-Woudenberg, I. A. J. M. (1995). Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immuno-competent mice and leukopenic mice infected with Candida albicans. Journal of Antimicrobial Chemotherapy 35, 509-19.